Technical Analysis for MYX - Mayne Pharma Group Ltd  

Grade Last Price % Change Price Change
grade C 0.47 2.17% 0.010
MYX closed up 2.17 percent on Wednesday, January 29, 2020, on 54 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Flat
Historical MYX trend table...

Date Alert Name Type % Chg
Crossed Above 50 DMA Bullish 0.00%
Fell Below 50 DMA Bearish 2.17%
20 DMA Support Bullish 2.17%
20 DMA Support Bullish 0.00%
Crossed Above 50 DMA Bullish 0.00%
180 Bullish Setup Bullish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
50 DMA Resistance Bearish 2.17%
50 DMA Resistance Bearish 0.00%
Upper Bollinger Band Walk Strength 0.00%

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Interactive chart

Profile

Mayne Pharma Group Limited is a specialty pharmaceutical company, which focuses on applying its drug delivery capability to commercialize branded and generic pharmaceuticals. The Company also provides contract development and manufacturing services. It operates in four segments: Generic Products (GPD), Specialty Brands (SBD), Metrics Contract Services (MCS) and Mayne Pharma International (MPI). The GPD segment is engaged in the manufacture and distribution of generic pharmaceutical products in the United States. The SBD segment markets and distributes specialty branded pharmaceutical products in the United States. The MCS segment is engaged in the provision of contract analytical and pharmaceutical development services to third-party customers in the United States. The MPI segment is engaged in Australian manufacture and sale of branded and generic pharmaceutical product globally and provision of contract manufacturing services to third-party customers within Australia.
Health Pharmaceutical Industry Pharmaceuticals Policy Pharmaceutical Pharmaceutical Industry In China Pharmaceutical Products Drug Delivery Science And Technology In The People's Republic Of China Generic Pharmaceutical Products

Is MYX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 0.85
52 Week Low 0.425
Average Volume 4,318,212
200-Day Moving Average 0.523
50-Day Moving Average 0.463
20-Day Moving Average 0.458
10-Day Moving Average 0.469
Average True Range 0.016
ADX 14.28
+DI 17.419
-DI 16.652
Chandelier Exit (Long, 3 ATRs ) 0.438
Chandelier Exit (Short, 3 ATRs ) 0.477
Upper Bollinger Band 0.487
Lower Bollinger Band 0.430
Percent B (%b) 0.71
BandWidth 12.445
MACD Line 0.003
MACD Signal Line 0.001
MACD Histogram 0.0016
Fundamentals Value
Market Cap 683.33 Million
Num Shares 1.45 Billion
EPS 0.06
Price-to-Earnings (P/E) Ratio 7.70
Price-to-Sales 1.77
Price-to-Book 0.78
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.493
Resistance 3 (R3) 0.492 0.483 0.489
Resistance 2 (R2) 0.483 0.478 0.484 0.487
Resistance 1 (R1) 0.477 0.474 0.480 0.478 0.486
Pivot Point 0.468 0.468 0.470 0.469 0.468
Support 1 (S1) 0.462 0.463 0.465 0.463 0.454
Support 2 (S2) 0.453 0.459 0.454 0.453
Support 3 (S3) 0.447 0.453 0.451
Support 4 (S4) 0.448